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ReviewGliotoxin biosynthesis is encoded by the gli gene cluster
in Aspergillus fumigatus. The biosynthesis of gliotoxin is
influenced by a suite of transcriptionally-active regula-
tory proteins and a bis-thiomethyltransferase. A self-
protection system against gliotoxin is present in A.
fumigatus. Several additional metabolites are also pro-
duced via the gliotoxin biosynthetic pathway. Moreover,
the biosynthesis of unrelated natural products appears
to be influenced either by gliotoxin or by the activity of
specific reactions within the biosynthetic pathway. The
activity of gliotoxin against animal cells and fungi, often
mediated by interference with redox homeostasis or
protein modification, is revealing new metabolic inter-
actions within eukaryotic systems. Nature has provided
a most useful natural product with which to reveal some
of its many molecular secrets.
Contextualizing and rethinking gliotoxin
Aspergillus fumigatus is an opportunistic fungal pathogen
and primarily infects immunocompromised individuals
where it can cause fatal invasive aspergillosis (IA) [1].
A. fumigatus exposure can also induce debilitating aspergil-
losis and allergy in immunocompetent individuals [2,3].
Selected secondary metabolites produced by A. fumigatus,
in particular siderophores and the non-ribosomal
peptide gliotoxin, are generally considered to be front-line
virulence factors [4,5]. Gliotoxin is an epipolythiodioxopi-
perazine (ETP) of molecular mass 326 Da, and contains a
disulfide bridge which can undergo repeating cleavage and
reformation, thereby resulting in a potent intracellular
redox activity (Figure 1) [6]. Indeed, the dithiol form
of gliotoxin has also been posited to be responsible for
the observed biological activities of gliotoxin [7].
Bisdethiobis(methylthio)gliotoxin (BmGT) and related
gliotoxin metabolites (Figure 1) are also biosynthesized by
A. fumigatus [8,9]. Incredibly, the gliotoxin biosynthetic
pathway had remained elusive since the discovery of glio-
toxin in 1936; however, recent studies have not only dissect-
ed this unusual molecular assembly system but have
revealed the necessity for gliotoxin-producing fungi to pos-
sess an endogenous resistance system against gliotoxin
[10,11]. Moreover, because gliotoxin can be considered as0966-842X/
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*These authors contributed equally to this work.the prototype ETP, studies on gliotoxin can be instrumental
in revealing the biosynthetic mechanisms of related ETPs
which are biosynthesized by a range of fungi [12]. Amongst
others, these include sirodesmin A, sporidesmin A, chaeto-
cin, aranotin, and chetomin [13]. Studies on the biosynthetic
mechanism of ETPs, particularly gliotoxin, are also serving
to inspire new synthetic chemistry approaches for ETP
synthesis and desulfurization, which are somewhat beyond
the scope of the present review [13,14].
In addition to studying how gliotoxin contributes to
organismal virulence, it has also been deployed to explore
and reveal novel biochemistry within both fungal and
animal cells [15,16]. Thus, we contend that it is the ability
of gliotoxin to interfere with so many cellular processes
that makes it such a useful tool to access the many impor-
tant, although occluded, systems interactions within fungi.
Indeed, emerging studies of the reciprocal effects of glio-
toxin on animal cells and fungi are serving to enhance our
view of gliotoxin as an antioxidant as much as a toxin
[6,17]. In this review we set out our current understanding
of gliotoxin biosynthesis, its regulation, and resistance
systems against gliotoxin. We also attempt to elucidate
how the effects of gliotoxin on fungi and animal cells can
cross-fertilize our knowledge of hitherto unknown aspects
of both eukaryotic cell systems.
Gliotoxin biosynthesis
The in silico identification of the gli cluster in A. fumigatus
(Figure 1) [18] paved the way for multiple functional
genomic studies which revealed that the gli cluster, com-
prising 13 genes, encodes the key enzymes responsible for
gliotoxin biosynthesis (Figure 2). The Zn(II)2-Cys(6) binuc-
lear cluster domain transcription factor gliZ was confirmed
as the regulator of the gli cluster [19], whereby deletion of
this gene abrogated the expression of key biosynthetic
genes and concomitant gliotoxin biosynthesis. Interesting-
ly, upon gliZ reconstitution in A. fumigatus DgliZ, the
biosynthesis of unrelated natural products was induced.
The non-ribosomal peptide synthetase, GliP, catalyzes the
formation of cyclo-phenylalanyl-serine, the first biosyn-
thetic intermediate in the gliotoxin biosynthetic pathway
[20], and multiple groups undertook gliP deletion, which
results in complete loss of gliotoxin biosynthesis [5,21–23]
(Figure 2). Interestingly, Cramer et al. observed that
exogenous gliotoxin induced gli cluster gene expression
in A. fumigatus, which was somewhat attenuated in
A. fumigatus DgliP [21]. Although not unheard of, it is
certainly unusual for a fungal natural product to induce its
own biosynthesis, and the biological significance of thisTrends in Microbiology, July 2015, Vol. 23, No. 7 419
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Figure 1. Interconversion of gliotoxin between the reduced (dithiol) and oxidized (disulfide) forms. In Aspergillus fumigatus the gli cluster, which encodes gliotoxin
biosynthesis and consists of 13 genes (in color and labeled with their last letter), is located on chromosome 6 [10,18]. gtmA is encoded outside the cluster and is on
chromosome 2. Multiple metabolites are produced via the activity of the gliotoxin biosynthetic pathway (shown at the bottom of the figure), including BmGT (indicated by
an asterisk) [9].
Review Trends in Microbiology July 2015, Vol. 23, No. 7phenomenon is only beginning to emerge. Cyclo-
phenylalanyl-serine is subsequently converted to a high-
ly-reactive acyl imine intermediate before bis-glutathiony-
lation. GliC has been shown to catalyze hydroxylation of
the a-carbon of L-Phe in cyclo-phenylalanyl-serine before
bis-glutathionylation [24]. The demonstration that gliG
encodes a glutathione S-transferase (GST), which conju-
gates two glutathione (GSH) molecules to a biosynthetic
intermediate to form a bis-glutathionylated biosynthetic
intermediate (Figure 2), and which is therefore responsible
for the sulfurization of gliotoxin, was an important
finding because it was one of the first demonstrations that
GSTs played a biosynthetic, as opposed to detoxification,
role in fungi [25,26]. This bis-glutathionylated intermedi-
ate is subsequently processed by GliK, a g-glutamyl
cyclotransferase, to remove both g-glutamyl moieties
[17,27]. Subsequent processing via GliI [28] yields a
biosynthetic intermediate, which is N-methylated via
the N-methyltransferase GliN, before the gliotoxin oxido-
reductase GliT-mediated disulfide bridge closure
(Figure 2) [27,29]. Gliotoxin secretion from A. fumigatus
ensues, now known to be facilitated in part by the MFS
transporter GliA [30].
Regulation of gliotoxin biosynthesis
Dolan et al. have identified a negative regulatory mecha-
nism which deploys a non-gli cluster encoded gliotoxin bis-
thiomethyltransferase, termed GtmA [8]. gtmA expression
is induced by gliotoxin, and GtmA (also termed TtmA in
[29]) functions to bis-thiomethylate dithiol gliotoxin to420form BmGT [8,29], instead of undergoing disulfide bridge
closure via GliT (Figure 2). Consequently, both gliotoxin
biosynthesis and auto-induction of the gli cluster are at-
tenuated. Importantly, this post-biosynthetic negative reg-
ulatory mechanism may be operative in other fungal ETP
biosynthetic systems because bis-thiomethylated ETPs are
produced by fungi, and GtmA orthologs have also been
identified across the ascomycetes [8,29]. Moreover, over-
production of gliotoxin or related ETPs for biotechnological
purposes may be dependent on utilizing bis-thiomethyl-
transferase-deficient strains to deactivate this negative
feedback system. Although GliH has been shown to be
essential for gliotoxin biosynthesis [10], to date the
function of this enzyme has not been elucidated.
Interestingly, apart from gliZ, many other transcription
factors and regulatory genes influence gliotoxin biosynthe-
sis (Table 1). The C2H2 transcription factor gipA regulates
gliA interdependently with gliZ [31]. In addition, it is well-
established that laeA, a global regulator of secondary
metabolism, which interacts with the velvet proteins
VeA and VelB in the nucleus [32–35], augments gliotoxin
biosynthesis because either laeA or veA deletion results in
impaired gliotoxin production in A. fumigatus [34,36].
Other transcription factors found to regulate the gli cluster
include mtfA (a C2H2 transcription factor [37]), rsmA
(a bZIP transcription factor [38]), and stuA (an APSES
family transcription factor [39,40]) (Table 1). The develop-
mental regulators flbB and flbE positively influence glio-
toxin biosynthesis because deletion mutants exhibit
reduced or abolished gliotoxin production [41–43]. The
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Figure 2. Gliotoxin biosynthesis, secretion, and regulation. A series of enzyme-catalyzed steps convert phenylalanine and serine to gliotoxin or BmGT via the formation of
reactive intermediates, bis-glutathionylation, degradation steps, methylation, and oxidation [10,11,15,20,25,26]. Dithiol gliotoxin, a co-substrate for either GliT or GtmA, is
converted to gliotoxin or BmGT, respectively [8,83]. Gliotoxin can induce gli cluster expression [21] or is secreted from A. fumigatus via GliA [30]; however, the process of
BmGT release is undefined. BmGT formation and secretion dissipate intracellular gliotoxin, thereby preventing gli cluster expression leading to downregulation of gliotoxin
biosynthesis [8]. Please note that the precise order of some reaction steps, and gliM/H involvement, remain to be fully elucidated.
Review Trends in Microbiology July 2015, Vol. 23, No. 7MAP kinase, mpkA, and the class 2 histone deacetylase,
hdaA, also positively regulate gliotoxin biosynthesis while
the histone methyltransferase, cclA, negatively regulates
gliotoxin production because increased gliotoxin levels
were evident in DcclA, consequent to increased gliZexpression [44] (Table 1). Thus, it is now apparent that
regulation of gliotoxin biosynthesis is a hierarchical, mul-
tifactorial process that is affected by many regulatory
elements, and which is highly integrated into A. fumigatus
metabolism.421
Table 1. Transcriptional regulators which impact upon gli cluster gene expression and gliotoxin biosynthesis
Transcriptional regulator Effect on gliotoxin biosynthesisa Other phenotypes Refs
GliZ
(Zn2Cys6 binuclear
transcription factor)
Essential for gliotoxin biosynthesis. Deletion
results in loss of expression of some of the other
gli cluster genes (e.g., gliI, gliA, gliG).
gliZ regulates the production of other SM (e.g.,
OEgliZ produced helvolic acid at 378C, unlike wild
type). Virulence in a mouse model is not
significantly different from wild type, although is
slightly decreased. Involved in apoptotic but not
necrotic cell death.
[10,19]
GipA
(C2H2 transcription factor)
Regulates gliotoxin biosynthesis genes;
decreased expression of gliA, gliZ, gliP, and gliT,
and consequently reduced gliotoxin production
in DgipA. Conversely, these genes had increased
expression in OEgipA.
The gli genes (except gliM) contain potential GipA
binding sites. GipA cannot induce gliA or gliP
expression independently of gliZ, while gliZ
induction of gliA is GipA-dependent.
GipA potentially induces other SM clusters
because at least one gene from 18 SM clusters
was increased in expression in an OEgipA strain.
[31]
LaeA
(transcriptional regulator)
Positively regulates gliotoxin biosynthesis
because gliotoxin production is impaired in
DlaeA.
Global regulator of SM production in A.
fumigatus because 13 of 22 SM clusters exhibited
reduced expression in DlaeA. DlaeA had reduced
virulence in a mouse model of IA. DlaeA conidia
were defective in rodlet production and had
increased susceptibility to macrophage
phagocytosis, while hyphae displayed decreased
ability to kill neutrophils. DlaeA demonstrated
impaired conidia and conidiophore production in
liquid shake culture.
[34,35]
VeA
(regulatory gene)
Positively regulates gliotoxin biosynthesis
because reduced gliotoxin production is evident
in DveA. gliZ and gliP expression are decreased in
DveA.
VeA predominantly positively regulates other SM
clusters; fumagillin, fumitremorgin G,
fumigaclavine C, and glionitrin A production is
reduced in DveA. VeA regulates development;
DveA demonstrates reduced conidiation but
increased pigmentation of conidia, reduced
protease activity, and increased expression of
brlA (a developmental activator) during
development compared to wild type. VeA is
dispensable for virulence in a neutropenic mouse
infection model. VeA is highly conserved; veA
from Aspergillus nidulans complements deletion
in A. fumigatus.
[36,84,85]
FlbA
(regulator of G-protein
signaling protein)
Does not affect gliotoxin biosynthesis; however,
expression of gliT and secretion of GliT are
increased in DflbA. Consequently, DflbA displays
enhanced tolerance to exogenous gliotoxin.
laeA expression is reduced in DflbA, suggesting
that other SM clusters may be effected by FlbA.
FlbA is necessary for normal cell death
progression and autolysis in submerged cultures.
DflbA has increased superoxide dismutase and
catalase activity, and demonstrated enhanced
resistance to menadione and paraquat. FlbA
downregulates hyphal differentiation by
inactivating GpaA, and thus induces asexual
development.
[86,87]
MpkA
(MAP kinase)
Regulates gliotoxin production which is reduced
in DmpkA compared to wild type. Expression of
gliN and gliT is decreased in DmpkA.
MpkA is activated by iron starvation, to which it
responds by reshuffling the amino acid pool
(increased ornithine levels) leading to increased
siderophore biosynthesis. DmpkA exhibits
increased sensitivity to menadione and diamide
but decreased sensitivity to H2O2. Involved in cell
wall integrity signaling.
[88,89]
MtfA
(C2H2 transcription factor)
Gliotoxin levels were increased in OEmtfA but
were unchanged in DmtfA. Expression of gliZ and
gliP was increased in OEmtfA.
Involved in growth and development; reduced
growth and conidiation was observed in DmtfA
and OEmtfA.
Positive regulator of protease production. DmtfA
exhibited attenuated virulence in Galleria
mellonella.
[37]
RsmA
(restorer of secondary
metabolism – A bZIP
transcription factor)
The production of 12 gli cluster metabolites was
increased 2–100-fold in the OErsmA strain
compared to wild type.
Involved in growth and oxidative stress
resistance; OErsmA exhibits a growth defect at
low growth temperature (258C). OErsmA mutants
show increased resistance to menadione.
[38]
CclA
(histone
methyltransferase)
Increased gliotoxin production in DcclA mediated
by a substantial increase in gliZ transcription.
Increased production of other unidentified
secondary metabolites. Severe growth defects
and sensitivity to 6-azauracil (6AU); an inhibitor of
guanine nucleotide synthesis and an indicator of
transcriptional defects.
[44]
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Table 1 (Continued )
Transcriptional regulator Effect on gliotoxin biosynthesisa Other phenotypes Refs
FlbB
[developmental regulator
containing a basic leucine-
zipper domain (bZIP)]
Drastically reduced gliotoxin production (85%)
in the DflbB mutant compared to wild type.
Delayed/reduced sporulation; precocious cell
death; lack of conidiophore development in
submerged culture, reduced (90%) fumagillin
production.
[42,90]
FlbE
(developmental regulator
interacts with FlbB)
Gliotoxin production was abolished in the DflbE
deletion strain.
Controls asexual development: deletion results in
reduced conidiation and delayed expression of
brlA and vosA. Necessary for salt-induced
development in liquid submerged culture.
[43,90]
HdaA
(class 2 histone
deacetylase)
Deletion of the hdaA gene decreased gliotoxin
production and overexpression of hdaA
increased gliotoxin production.
DhdaA demonstrated a reduction in both
germination rate and vegetative growth; altered
colony morphology and increased expression of
several NRPS genes.
[50]
StuA
(APSES family
transcription factor)
gliP expression, and likely gliotoxin production,
are dependent on StuA in vivo.
DstuA had severely impaired conidiation; six
secondary metabolite clusters were found to be
regulated by StuA.
[39,40]
aAbbreviations: IA, invasive aspergillosis; OE, overexpressed; SM, secondary metabolite.
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Figure 3. Differential resistance to extracellular gliotoxin following selected gli
cluster gene and gtmA deletion in Aspergillus fumigatus. Combined deletion of
gliotoxin oxidoreductase gliT and MFS transporter gliA results in the most
gliotoxin-sensitive deletion strain [30], along with DgliT. A. fumigatus wild type
(WT), DgliG, DgtmA and DgliZ exhibit intact gliotoxin-resistance, while DgliK and
DgliA exhibit intermediate sensitivity.
Review Trends in Microbiology July 2015, Vol. 23, No. 7Histone H3 lysine 9 (H3K9) methyltransferase inhibition
Gliotoxin, and indeed other ETPs (e.g., chetomin and
chaetocin), are inhibitors of H3K9 methyltransferases,
which has been demonstrated using recombinant enzymes
[45,46]. The disulfide bond of ETP molecules is crucial for
this inhibition because ETPs in which the thiols are ren-
dered unreactive (e.g., bis-dethiobisacetylgliotoxin and
chaetocin with methylated sulfur groups) do not display
inhibitory abilities [45,46]. While direct investigations of
the effects of gliotoxin on histone H3K9 methyltrans-
ferases in A. fumigatus or other filamentous fungi have
not been performed to the best of our knowledge, functional
studies of histone-modifying enzymes have been carried
out (reviewed in [47]). Disruption of histone modifications,
in particular methylation and acetylation of histone H3 tail
residues, has been linked with alterations in not only
gliotoxin production but also in secondary metabolite pro-
duction in general in the Aspergilli [47–49]. A member of
the conserved eukaryotic H3K4 methylating COMPASS
complex, CclA, is required for tri- and di-methylation of
H3K4 and regulates secondary metabolite production
[44,48]. Deletion of cclA resulted in increased production
of gliotoxin and other secondary metabolites, leading to the
conclusion that tri- and di-methylation of H3K4 play a part
in secondary metabolite production in A. fumigatus [44]. In
addition, the class 2 histone deacetylase, HdaA, also reg-
ulates secondary metabolite production – deletion was
shown to increase production of several secondary metab-
olites but decrease the production of gliotoxin, while con-
versely a strain overexpressing hdaA had increased
gliotoxin biosynthesis [50]. Interestingly, H3K9 methyla-
tion levels were slightly higher in DhdaA compared to wild
type. Undoubtedly, further work will be necessary to ex-
plore the interactions, if any, between histone modification
and gliotoxin biosynthesis.
Self-protection against gliotoxin
The presence of cytochrome P450 monooxygenases and GST
involvement in ETP, specifically gliotoxin, biosynthesis is
reminiscent of a phase I/II detoxification system (C. Davis,
PhD thesis, National University of Ireland Maynooth, 2011)
[26]. Consequently, it is plausible that gliotoxin biosynthesis
evolved from an ancestral detoxification system and thatgliotoxin, or a biosynthetic intermediate, conferred a signif-
icant competitive advantage on the host organism. Indeed, it
is now clear [25,26] that A. fumigatus sacrifices reducing
power (2 GSH) to enable gliotoxin biosynthesis, and it is
therefore not inconceivable that enhanced redox homeosta-
sis, antimicrobial defense, or even redox-mediated signal-
ing, as a consequence of gliotoxin biosynthesis – and
presence – drove cluster evolution. However, the selective
advantage conferred upon ETP-producing organisms came
at a price, and self-protection against redox-active molecular
species is also an essential characteristic in these species.
Specifically, in addition to effecting disulfide bridge closure
during gliotoxin biosynthesis, GliT has been shown to confer
resistance against exogenous gliotoxin [10,11] (Figure 3).
Moreover, gliT expression is induced by gliotoxin indepen-
dently of gliZ [10], which further underpins its essential role
in self-protection. Interestingly, the alternative transcrip-
tion factor which influences gliZ-independent gliT expres-
sion remains elusive.
GliA-mediated gliotoxin efflux from A. fumigatus con-
tributes to self-protection [30] (Figures 2 and 3), and SirA,
a GliA ortholog in Leptosphaeria maculans, likewise con-
fers resistance to exogenous sirodesmin [51]. A. fumigatus423
Review Trends in Microbiology July 2015, Vol. 23, No. 7DgliA:DgliT is also highly sensitive to exogenous gliotoxin
(Figure 3), and this led Wang et al. [30] to conclude that
they represent independent self-protection systems. How-
ever, an alternative hypothesis whereby GliT-mediated
gliotoxin oxidation is necessary for GliA-mediated efflux
is also compatible with their experimental observations.
These authors also observed that attenuated gliotoxin
levels are secreted by A. fumigatus DgliA and they posited
the existence of an alternative gliotoxin efflux mechanism.
However, demonstration of a supplementary secretion
system remains outstanding. The identification of bis-thio-
methylated holomycin in the bacteria Streptomyces clavu-
ligerus, and its role in deactivation of the dithiol ‘warhead’,
led to speculation about the presence of a back-up self-
protection system catalyzed by gliM/gliN (methyltrans-
ferases) encoded within the gli cluster in A. fumigatus
(Figure 1) [52]. However, it appears that GtmA is the sole
enzyme responsible for BmGT formation in A. fumigatus
and that its primary role is the diminution of gliotoxin
biosynthesis and not as a back-up self-protection system
involving the direct detoxification of dithiol gliotoxin via
bis-thiomethylation [8]. Indeed, deletion of gtmA has no
significant impact on sensitivity of A. fumigatus to exoge-
nous gliotoxin (Figure 3), which implies that GliT is the key
mediator of this self-protection system.
The gliotoxin-related metabolome
Increasingly, examples of fungal secondary metabolite
cross-talk, whereby abrogation or overproduction of one
secondary metabolite may affect the production of another
apparently unrelated metabolite are emerging, as
reviewed in [53]. This phenomenon has been described
in A. fumigatus in relation to gliotoxin biosynthesis, where-
by overexpression of gliZ led to helvolic acid production at
378C which was not observed in wild type, while the
production of multiple metabolites was altered by the loss
or gain of gliZ, suggesting that gliZ may influence the
biosynthesis of secondary metabolites other than gliotoxin
[19]. In a later study employing 2D NMR spectroscopy
(DANS) which compared metabolite extracts from wild
type and DgliZ, nine novel gliZ-dependent metabolites
were identified in addition to previously identified metab-
olites [9] (Figure 1).
Disruption of gliotoxin biosynthesis in A. fumigatus
DgliK prevents the degradation and recycling of 2 mol
GSH per mol gliotoxin produced, and this resulted in
the concomitant acquisition of an oxidative stress pheno-
type accompanied by the first identification of the antioxi-
dant ergothioneine (EGT) in A. fumigatus [17]. Moreover,
significantly elevated EGT levels, possibly due to altered
redox homeostasis, were evident in A. fumigatus DgliK
[17]. The systems significance of the interactions between
these three redox-active species, GSH, gliotoxin, and EGT,
remains to be elucidated. In addition, significantly
increased levels of two unrelated metabolites of m/z
394 and 396 were also reported, implying that disruption
of gliotoxin biosynthesis, specifically via gliK deletion, influ-
ences the production of other, unrelated natural products
[17]. Further evidence of this phenomenon was observed in
A. fumigatus DgliT where production of brevianamide F was
significantly increased, while production of tryprostatin A424and B, fumagillin, and pseurotin A was significantly de-
creased [54]. This suggests that although GliT-mediated
disulfide bridge closure is required for gliotoxin biosynthe-
sis, abrogation of this redox reaction dysregulates the bio-
synthesis of other secondary metabolites, raising the
question as to whether this is the case in other microbial
species with similar disulfide bridge-forming systems (e.g.,
holomycin in Streptomyces clavuligerus and Yersinia ruck-
eri) [55,56]. In any case, it is now clear that disruption of
gliotoxin biosynthesis in A. fumigatus is a trans-consequen-
tial event which has far-reaching effects on secondary me-
tabolism, possibly as a result of A. fumigatus compensating
for the loss of gliotoxin-influenced redox homeostasis.
Gliotoxin functionality in fungi
With the discovery of GliT as the key to A. fumigatus self-
protection against gliotoxin toxicity [10,11], and the dem-
onstration of how gliotoxin can inhibit growth of Aspergilli
and pathogenic fungi such as Candida albicans [57,92], the
intriguing questions of the true in vivo role(s) of this
molecule and the in vivo effects upon fungi, either gliotoxin
producers or not, was brought to the fore. While the exact
mode of action of gliotoxin in vivo remains to be fully
elucidated, studies in yeast, Aspergillus spp., and mamma-
lian cell lines have demonstrated that elevated intracellu-
lar levels of GSH can exacerbate toxicity [15,58,59],
effectively by reducing the gliotoxin disulfide bridge to
yield reactive dithiol gliotoxin and thus allowing many
as-yet unidentified detrimental interactions to occur be-
tween reduced gliotoxin and essential cellular components.
The importance of elevated GSH levels in mediating glio-
toxin toxicity in fungi is particularly highlighted by the
ability of yeast deleted for gsh1 (the gene encoding g-
glutamylcysteine synthetase which is essential for GSH
biosynthesis) to grow much better than wild type in the
presence of high levels of exogenous gliotoxin, and by the
elevated GSH levels in gliotoxin-sensitive A. fumigatus
DgliT [15].
In an attempt to gain insight into the in vivo effects of
gliotoxin exposure, Chamilos and colleagues [60] screened
a yeast deletion library to identify strains that were sensi-
tive or resistant to exogenous gliotoxin compared to wild
type. While a number of gene deletions caused changes in
the gliotoxin exposure profile, of particular note was the
finding that deletion of cys3, which encodes a cystathionine
g-lyase, caused sensitization to gliotoxin. Cys3 is the sec-
ond enzyme in the reverse transulfuration pathway and is
responsible for converting homocysteine, a product of S-
adenosylmethionine metabolism, to cysteine [61]. Given
recent studies demonstrating the importance of GSH in
mediating gliotoxin sensitivity [15,17], and a recent global
transcriptome study demonstrating major alterations in
sulfur metabolism genes in A. fumigatus DgliT upon glio-
toxin exposure [54], the finding that cys3 deletion sensi-
tizes yeast to gliotoxin alludes to evolutionarily conserved
in vivo molecular responses to gliotoxin exposure and
perhaps toxicity.
The exposure of mammalian cells to gliotoxin increases
the levels of reactive oxygen species (ROS) [62], and dele-
tion of yeast genes responsible for dealing with oxidative
stress causes cells to be sensitized to gliotoxin [15].
Review Trends in Microbiology July 2015, Vol. 23, No. 7However, the relationship between gliotoxin and oxidative
stress induction is complicated. In addition to the afore-
mentioned relationship between GSH and gliotoxin, recent
studies in fungi have demonstrated that the presence of
gliotoxin can increase survival and growth when A. fumi-
gatus is cultured in the presence of high levels of growth-
inhibiting H2O2 [17]. Moreover, gliotoxin can directly re-
duce the levels of ROS produced in A. fumigatus when
exposed to H2O2, suggesting that under appropriate con-
ditions gliotoxin can exert antioxidant activities [63]. While
the mechanism of such activity remains to be elucidated, it
is clear from proteomic studies that gliotoxin exposure,
either alone or in combination with H2O2, can have far-
reaching effects on a variety of central metabolic processes
such as amino acid and purine metabolism in fungi [63]. It
is not inconceivable that these global changes in the fungal
proteome each provide a systems-level contribution to
alleviating oxidative stress induced by H2O2 exposure.
Gliotoxin impact on animal cells
Gliotoxin and related ETPs directly inactivate multiple
enzymes and proteins in animal cells, including nuclear
factor-kB (NF-kB), NADPH oxidase, and glutaredoxin, by
conjugation to thiol groups [64–66]. It has been conclusively
demonstrated that gliotoxin is taken up by animal cells in a
GSH-dependent manner whereby this normally protective
molecular species facilitates the concentration of gliotoxin
within animal cells [59]. Specifically, upon uptake intracel-
lular gliotoxin is reduced to the dithiol form, resulting in
GSH depletion and concomitant formation of GSSG. Apo-
ptosis ensues, followed by oxidation of dithiol gliotoxin to re-
form gliotoxin [59]. Gliotoxin then effluxes from the cell in a
pseudocatalytic manner and may be taken up by adjacent
cells to continue its cytocidal effects. In addition to having an
essential role in gliotoxin biosynthesis as a sulfur donor
[25,26], GSH has also been shown to have an important role
in mediating gliotoxin-induced cytotoxicity in animal cells
and fungi. Interestingly, diminution of intracellular GSH
levels using L-buthionine-sulfoxamine (BSO), a specific in-
hibitor of GSH synthesis, significantly attenuated the cyto-
toxic effect of gliotoxin towards human neuroblastoma SH-
SY5Y cells, possibly due to a deficit in GSH-mediated cleav-
age of the disulfide bridge of gliotoxin to produce reactive
dithiol gliotoxin [58]. This study highlighted the seemingly
contradictory effects of antioxidants in enhancing cellular
sensitivity to disulfide compounds.
Peroxiredoxins (Prxs) constitute a ubiquitous family of
antioxidant enzymes that catalyze the reduction of perox-
ides. This is achieved with two electrons derived from
NADPH via an electron-conveying system comprising thior-
edoxin and thioredoxin reductase. Nanomolar levels of glio-
toxin can protect against oxidative damage by converting
H2O2 to water in HeLa cells, where it functions to accept
electrons from NADPH in the thioredoxin redox system
[6]. Gliotoxin could, in turn, attenuate H2O2-induced
angiogenesis in a dose-dependent manner, thereby acting
as an anti-angiogenic agent. This anti-angiogenic effect of
A. fumigatus was completely attenuated by deletion of
laeA, the global regulator of secondary metabolism
[67]. These studies also revealed that gliotoxin was respon-
sible for approximately 50% of this anti-angiogenic activitybecause culture extracts from A. fumigatus DgliP, deficient
in gliotoxin biosynthesis only, did not abolish angiogenesis.
In murine melanoma cells, Prx II silencing enhanced lung
metastasis in vivo. Gliotoxin, owing to its ability to exert a
Prx-like activity, inhibited the proliferation and migration
as well as lung metastasis of Prx II-deficient melanoma cells.
This in vivo study implicated the Prx II mimetic ability of
gliotoxin as a promising therapeutic drug for preventing
melanoma metastasis [68].
Further studies have dissected the molecular basis and
investigated applications of ETP-mediated anti-angiogen-
esis. Tumor cells must adapt to a hypoxic environment to
survive and grow. This is mediated by hypoxia-inducible
factor (HIF-1), whereby the O2-regulated HIF-1a subunit
of the HIF-1 transcription factor is required for activation
of multiple genes involved in tumor progression and an-
giogenesis [69]. Under hypoxic conditions, HIF-1a under-
goes nuclear translocation where it interacts with HIF-1b
and binds to target DNA sequences. Upon recruitment of
additional proteins (e.g., p300), gene expression is activat-
ed to mount an adaptive response to hypoxia [70]. It has
been speculated that disruption of this hypoxic response
could form an effective anticancer strategy. Interestingly,
gliotoxin and the ETPs chaetocin and chetomin can inhibit
the HIF-1a–p300 interaction by ejecting an essential Zn2+
cofactor from p300 via the formation of a Zn2+(ETP)2
moiety [71]. Moreover, exposure to gliotoxin resulted in
anti-proliferative effects on cultured tumor cells, which
were reversible by Zn2+ supplementation. Furthermore,
Zn2+ can protect HepG2 cells against toxicity of the ETP
sporidesmin from Pithomyces chartarum which causes
facial eczema in sheep [72]. Indeed, Zn2+ supplementation
of ruminant diets is an effective prophylactic treatment for
this disease [73]; it is tempting to speculate that this could
be effected via disruption of the HIF-1a–p300 adaptive
response. More recently it has been shown that gliotoxin,
chaetocin, and chetomin could significantly decrease tumor
growth in a prostate cancer xenograft model system
[69]. Although gliotoxin exposure did not impact on the
expression of HIF-1a regulated genes, these authors spec-
ulated that the antitumor activity of gliotoxin could be
mediated via farnesyltransferase inhibition because inhi-
bition of this enzyme can attenuate angiogenesis by inter-
fering with endothelial cell migration [74].
As described in Figure 4, gliotoxin induces apoptotic cell
death by activating the pore-forming proapoptotic Bcl-2
family member Bak to elicit ROS generation, the mito-
chondrial release of apoptogenic factors, and caspase-3
activation. Thus, not only has this work elucidated the
mechanism of gliotoxin-induced apoptosis but also it has
uncovered the molecular mechanisms of Bcl-2 family initi-
ation [16,75]. It is possible that induction of gliotoxin-
dependent apoptosis could impact on the severity and
course of Aspergillus infection by destroying lung epitheli-
um or by killing alveolar macrophages [62]. NF-kB is a
ubiquitously expressed proinflammatory transcription fac-
tor composed of different combinations of members of the
Rel family of proteins. As shown in Figure 4 gliotoxin has
been well-characterized as an inhibitor of NF-kB activation
[64], and this then led to a plethora of studies which utilize
gliotoxin as a specific NF-kB inhibitor [76–78]. Gliotoxin425
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Figure 4. Gliotoxin induction of apoptosis in mammalian cells through various specific cellular targets. Upstream of the pore-forming proapoptotic Bcl-2 family member Bak,
gliotoxin-mediated apoptosis requires the c-Jun N-terminal kinase 1 and 2 (JNK1/2)-mediated phosphorylation (P) of the BH3-only protein BimEL at three sites (S100, T112, and
S114). This triple phosphorylation increases the stability of BimEL, increases its binding affinity for Bcl-2-like survival factors, and activates Bak more effectively. Notably, triple-
mutated Bim is unable to transduce the gliotoxin–JNK-initiated apoptotic stimulus to Bak. Compared to wild type, mice lacking Bak were significantly less susceptible to A.
fumigatus infection, which demonstrates the in vivo relevance of this gliotoxin-induced apoptotic pathway [16,62,75]. In resting cells, NF-kB is localized to the cytoplasm
because of binding to inhibitory protein IkB. Upon activation, NF-kB inducing kinase (NIK) is activated, which in turn activates a complex of specific IkB kinases (IKKs) resulting in
IkB phosphorylation. Phosphorylation of IkB leads to a rapid ubiquitination (Ub) which makes it a substrate for the proteasome. The active NF-kB complex then translocates to
the nucleus and initiates the expression of target genes. Gliotoxin inhibits NF-kB activation by preventing IkB degradation [64]. Gliotoxin also suppresses NF-kB activation by
inhibiting the linear ubiquitin (Ub) chain assembly complex (LUBAC). This is the first selective small-molecule inhibitor of this complex to be identified [91]. Abbreviations:
Apaf1, apoptotic protease activating factor 1; FAK, focal adhesion kinase; HOIL-1L, heme-oxidized IRP2 ubiquitin ligase-1; HOIP, HOIL-1L interacting protein; ILK, integrin-linked
kinase; NEMO, NF-kB essential modulator; SHARPIN, SHANK-associated RH domain interacting protein; Src, Sarcoma family nonreceptor protein tyrosine kinase.
Box 1. Outstanding questions
 What are the roles of gliH and gliM in gliotoxin biosynthesis?
 What are the interactions and roles of the many regulatory genes
which appear to control gliotoxin biosynthesis?
 What is the mechanism of independent regulation of gliT
expression?
 How can the interplay between gliotoxin and other natural
product biosynthetic pathways in A. fumigatus be elucidated?
 What is the redox systems significance of the interplay between
GSH, EGT, and gliotoxin in fungi?
 Is there an anticancer role of gliotoxin and related ETPs? Can its
role as a probe of cellular systems in animal cells be further
developed?
Review Trends in Microbiology July 2015, Vol. 23, No. 7has also been utilized to demonstrate that NF-kB inhibi-
tion reverses tumor necrosis factor-a (TNF-a)-induced eo-
sinophil survival, highlighting the major role of NF-kB in
TNF-a-induced inhibition of eosinophil apoptosis [79]. It is
clear from these selected studies that gliotoxin is a potent
small molecule capable of targeting and revealing multiple
aspects of animal cell biochemistry.
Concluding remarks
Our knowledge of gliotoxin biosynthesis, functionality, and
utility has increased dramatically over recent years
[80]. Specifically, it is now clear that gliotoxin biosynthesis
(i) involves novel enzymology, (ii) unusually deploys GSH
as a substrate for biosynthetic intermediate sulfurization,
(iii) has resulted in the evolution of a self-protection system
mediated by GliT, (iv) results in the production of a suite of
additional related metabolites (some with diagnostic po-
tential [38,81]), and (v) is post-biosynthetically negatively
regulated by GtmA activity. Reconsidering the established
view of gliotoxin as a ‘toxin’, it is becoming increasingly426clear that its antioxidant and signaling roles [82] need
further evaluation and study. Whether this antioxidant
ability is related to the influence that gliotoxin, or pathway
components, exert on the biosynthesis of unrelated metab-
olites in A. fumigatus remains to be established (Box 1).
GSH-mediated reduction of gliotoxin in animal cells and
Review Trends in Microbiology July 2015, Vol. 23, No. 7fungi appears to be central to the potency of the metabolite
to alter and impair cellular systems. In the future, contex-
tualization of gliotoxin effects on eukaryotic cells may
benefit from cognizance of its multiple actions and reactiv-
ity of dithiol gliotoxin. Moreover, in fungi capable of glio-
toxin biosynthesis, we now know that exogenous gliotoxin
induces gli cluster expression and concomitant gliotoxin
biosynthesis [21,54]; the impacts and utility of these obser-
vations cannot be underestimated.
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